CIK: 0001615982
Total reported value
$2.7B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | APGE | Apogee Therapeutics INC | Stock-Other | 18.99% | -4.99% | — | |
| 2 | ✓ | Stock-Other | 11.05% | — | — | ||
| 3 | OCUL | Ocular Therapeutix INC | Stock-Other | 8.66% | -1.12% | +3.13% | |
| 4 | CDTX | Cidara Therapeutics INC | Stock-Other | 5.10% | — | +48.15% | |
| 5 | VRDN | Viridian Therapeutics INC | Stock-Other | 4.72% | -3.14% | — | |
| 6 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 4.61% | -0.51% | — | |
| 7 | ORKA | Oruka Therapeutics INC | Stock-Other | 4.49% | +1.39% | — | |
| 8 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 4.46% | -0.25% | — | |
| 9 | ELVN | Enliven Therapeutics INC | Stock-Other | 3.72% | +0.08% | -19.87% | |
| 10 | COGT | Cogent Biosciences INC | Stock-Other | 3.23% | -0.64% | -15.89% | |
| 11 | CTMX | Cytomx Therapeutics INC | Stock-Other | 2.79% | -1.52% | +11.39% | |
| 12 | ABVX | Abivax Sa-adr | Stock-Other | 2.76% | — | -57.15% | |
| 13 | SVRA | Savara INC | Stock-Other | 2.55% | -1.29% | +42.74% | |
| 14 | SYRE | Spyre Therapeutics INC | Stock-Other | 2.53% | +0.98% | — | |
| 15 | ERAS | Erasca INC | Stock-Other | 2.19% | +6.61% | — | |
| 16 | DNTH | Dianthus Therapeutics INC | Stock-Other | 2.13% | +1.66% | -3.92% | |
| 17 | ✓ | Engene Holdings INC | Stock-Other | 1.94% | -0.92% | — | |
| 18 | MAZE | Maze Therapeutics INC | Stock-Other | 1.80% | -1.39% | — | |
| 19 | JBIO | Jade Biosciences INC | Stock-Other | 1.56% | -0.76% | — | |
| 20 | DYN | Dyne Therapeutics INC | Stock-Other | 1.55% | -0.63% | — | |
| 21 | VOR | Vor Biopharma INC | Stock-Other | 1.37% | +0.77% | — | |
| 22 | UPB | Upstream Bio INC | Stock-Other | 1.24% | -1.57% | EXIT | |
| 23 | ✓ | Zura Bio LTD | Stock-Other | 1.13% | +0.05% | — | |
| 24 | CATBUSD | Astria Therapeutics INC | Stock-Other | 1.01% | — | — | |
| 25 | PHVS | Pharvaris N.V. | Stock-Other | 0.95% | — | -67.05% | |
| 26 | ✓ | Crescent Biopharma INC. | Stock-Other | 0.93% | +0.21% | — | |
| 27 | SEPN | Septerna INC | Stock-Other | 0.65% | -0.39% | +13.02% | |
| 28 | CGEM | Cullinan Therapeutics INC | Stock-Other | 0.46% | +0.02% | — | |
| 29 | SRZN | Surrozen INC | Stock-Other | 0.46% | -0.02% | — | |
| 30 | ✓ | Stock-Other | 0.45% | — | — | ||
| 31 | ARTV | Artiva Biotherapeutics INC | Stock-Other | 0.26% | +0.05% | — | |
| 32 | TENX | Tenax Therapeutics INC | Stock-Other | 0.19% | +1.00% | NEW | |
| 33 | ✓ | Casi Pharmaceuticals INC | Stock-Other | 0.09% | -0.04% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CDTX | Cidara Therapeutics INC | +3.2% | +48.15% | Trim |
| 2 | ORIC | Oric Pharmaceuticals INC | +3% | — | Add |
| 3 | ✓ | +2.4% | — | Unchanged | |
| 4 | ABVX | Abivax Sa-adr | +2% | -57.15% | Trim |
| 5 | SVRA | Savara INC | +1.8% | +42.74% | Add |
| 6 | ORKA | Oruka Therapeutics INC | +0.9% | — | Unchanged |
| 7 | OCUL | Ocular Therapeutix INC | +0.7% | +3.13% | Add |
| 8 | ✓ | Zura Bio LTD | +0.6% | — | Trim |
| 9 | COGT | Cogent Biosciences INC | +0.3% | -15.89% | Trim |
| 10 | ERAS | Erasca INC | +0.3% | — | Add |
| 11 | VRDN | Viridian Therapeutics INC | +0.3% | — | Unchanged |
| 12 | TENX | Tenax Therapeutics INC | +0.1% | +344.09% | Add |
| 13 | UPB | Upstream Bio INC | 0% | -49.06% | Trim |
| 14 | ✓ | Engene Holdings INC | 0% | — | Unchanged |
| 15 | ✓ | Casi Pharmaceuticals INC | -0.1% | — | Unchanged |
| 16 | CATBUSD | Astria Therapeutics INC | -0.1% | — | Unchanged |
| 17 | ARTV | Artiva Biotherapeutics INC | -0.2% | — | Unchanged |
| 18 | SRZN | Surrozen INC | -0.2% | — | Unchanged |
| 19 | ✓ | -0.2% | — | Unchanged | |
| 20 | DYN | Dyne Therapeutics INC | -0.4% | — | Unchanged |
| 21 | CGEM | Cullinan Therapeutics INC | -0.4% | — | Unchanged |
| 22 | DNTH | Dianthus Therapeutics INC | -0.6% | -3.92% | Trim |
| 23 | SYRE | Spyre Therapeutics INC | -1.2% | — | Unchanged |
| 24 | 4XC1 | Kalvista Pharmaceuticals INC | -2% | — | Add |
| 25 | ELVN | Enliven Therapeutics INC | -3% | -19.87% | Trim |
| 26 | PHVS | Pharvaris N.V. | -3.2% | -67.05% | Trim |
| 27 | APGE | Apogee Therapeutics INC | -8% | — | Unchanged |
| 28 | CTMX | Cytomx Therapeutics INC | — | NEW | New buy |
| 29 | PRAX | Praxis Precision Medicines I | — | EXIT | Sold out |
| 30 | MAZE | Maze Therapeutics INC | — | NEW | New buy |
| 31 | JBIO | Jade Biosciences INC | — | NEW | New buy |
| 32 | VOR | Vor Biopharma INC | — | NEW | New buy |
| 33 | ✓ | Crescent Biopharma INC. | — | NEW | New buy |
| 34 | SEPN | Septerna INC | — | NEW | New buy |
| 35 | SLDB | Solid Biosciences INC | — | EXIT | Sold out |
| 36 | TRVI | Trevi Therapeutics INC | — | EXIT | Sold out |
| 37 | APLT | Applied Therapeutics INC | — | EXIT | Sold out |
| 38 | FDMT | 4d Molecular Therapeutics In | — | EXIT | Sold out |
| 39 | ✓ | Mersana Therapeutics INC | — | EXIT | Sold out |
| 40 | IPSC | Century Therapeutics INC | — | EXIT | Sold out |
| 41 | TNYA | Tenaya Therapeutics INC | — | EXIT | Sold out |
| 42 | GLYCEUR | Glycomimetics INC | — | EXIT | Sold out |
| 43 | TIL | Instil Bio INC | — | EXIT | Sold out |